Laurence Reilly

Director/Board Member at IMMUPHARMA PLC

42 year

Health Technology

Consumer Services

Profile

Laurence Reilly is currently a Senior Independent Non-Executive Director at ImmuPharma Plc and a Vice President-Research & Investments at Royalty Pharma Plc.
He previously worked as the Chief Scientific Officer & Vice President at Avillion LLP and as the Chief Medical Officer at Cellectar Biosciences, Inc. Reilly holds a doctorate degree from The University of Liverpool and a graduate degree from De Montfort University.

Laurence Reilly active positions

Companies	Position	Start
IMMUPHARMA PLC	Director/Board Member	2023-08-10
ROYALTY PHARMA PLC	Corporate Officer/Principal	-

All active positions of Laurence Reilly

Former positions of Laurence Reilly

Companies	Position	End
Avillion LLP Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.	Chief Tech/Sci/R&D Officer	-
CELLECTAR BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Laurence Reilly's experience

Training of Laurence Reilly

The University of Liverpool	Doctorate Degree
De Montfort University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Laurence Reilly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
IMMUPHARMA PLC	Health Technology
CELLECTAR BIOSCIENCES, INC.	Health Technology
ROYALTY PHARMA PLC	Health Technology

Private companies	1
Avillion LLP Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.	Health Technology